Medicine
Naloxone 2 mg/2 mL injection
Naloxone 2 mg/2 mL injection is a generic prescription medicine for intramuscular, intravenous, subcutaneous use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Protect from light. Store in carton…
Key facts
- Active ingredient (INN)
- Naloxone
- Brand
- Sold under the generic name
- Strength
- 2 mg/2 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous, subcutaneous
- Packs
- 10 syringes of 2 mL, 1 syringe of 2 mL, 10 cartons of 2 mL and 12 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaEugiaIndiaHealthFirstBaxter HealthcareFresenius KabiHikma PharmaceuticalsMedical Purchasing SolutionsMylan InstitutionalPar Health
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Protect from light. Store in carton until time of use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A06AH04 Naloxone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 March 2020
- Identifiers
- RxCUI 1191250, 2679504DailyMed set ID 3ae08e26-223b-4971-b2f1-f1e183a3f930, 201fdedf-1736-4e52-9d7d-de14292547fd, e65e03c1-9a66-b30b-e053-2995a90aeb73 +8NDC 42023-224, 76045-112, 51662-1586 +8Application ANDA215964, ANDA213573, ANDA213279 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 syringe in 1 box / 2 mL in 1 syringe | 43598-750-10 | Dr. Reddy's LaboratoriesIndia | 10 September 2024 |
| 1 syringe in 1 box / 2 mL in 1 syringe | 43598-750-11 | Dr. Reddy's LaboratoriesIndia | 18 March 2020 |
| 1 syringe in 1 box / 2 mL in 1 syringe | 55150-345-01 | EugiaIndia | 14 January 2021 |
| 10 syringe in 1 box / 2 mL in 1 syringe | 55150-345-10 | EugiaIndia | 14 January 2021 |
| 10 carton in 1 carton / 1 syringe, glass in 1 carton / 2 mL in 1 syringe, glass | 43066-142-10 | Baxter Healthcare | 3 June 2025 |
| 24 syringe in 1 case / 2 mL in 1 syringe | 76045-112-20 | Fresenius Kabi | 2 April 2024 |
| 10 syringe in 1 carton / 2 mL in 1 syringe | 0641-6205-10 | Hikma Pharmaceuticals | 10 June 2022 |
| 1 syringe, glass in 1 carton / 2 mL in 1 syringe, glass | 67457-992-02 | Mylan Institutional | 2 December 2022 |
| 1 syringe, glass in 1 carton / 2 mL in 1 syringe, glass | 42023-224-01 | Par Health | 5 November 2024 |
| 1 syringe in 1 box / 2 mL in 1 syringe | 51662-1529-1 | HealthFirst | 15 July 2021 |
| 10 pouch in 1 box / 1 syringe in 1 pouch / 2 mL in 1 syringe | 51662-1529-3 | HealthFirst | 11 May 2022 |
| 1 syringe in 1 box / 2 mL in 1 syringe | 51662-1586-1 | HealthFirst | 16 August 2022 |
| 10 pouch in 1 case / 1 box in 1 pouch / 1 syringe in 1 box / 2 mL in 1 syringe | 51662-1586-3 | HealthFirst | 16 August 2022 |
| 10 pouch in 1 case / 1 box in 1 pouch / 1 syringe in 1 box / 2 mL in 1 syringe | 51662-1690-3 | HealthFirst | 18 March 2020 |
| 1 syringe in 1 bag / 2 mL in 1 syringe | 71872-7299-1 | Medical Purchasing Solutions | 25 January 2023 |
| 10 syringe in 1 box / 2 mL in 1 syringe | 76329-1469-1 | — | 1 April 1998 |
| 10 syringe in 1 box / 2 mL in 1 syringe | 76329-3369-1 | — | 1 June 2001 |
| 10 syringe in 1 box / 2 mL in 1 syringe | 76329-3469-1 | — | 28 July 2016 |
| 1 syringe in 1 bag / 2 mL in 1 syringe | 71872-7177-1 | — | 9 September 2019 |
| 1 syringe in 1 bag / 2 mL in 1 syringe | 71872-7294-1 | — | 22 July 2022 |
| 1 syringe, plastic in 1 box / 2 mL in 1 syringe, plastic | 51662-1239-1 | — | 3 September 2018 |
| 1 syringe in 1 bag / 2 mL in 1 syringe | 0404-9922-02 | — | 13 January 2022 |
| 10 syringe in 1 box / 2 mL in 1 syringe | 70518-2725-0 | — | 5 May 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Naloxone 2 mg/2 mL injection.
Other strengths and forms of Naloxone
Clinical summary
Naloxone is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. MedsAcross supplies Naloxone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NaloxoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Narcan prescribing information (Emergent Devices) · U.S. National Library of Medicine, DailyMed
- Nyxoid: European public assessment report (EPAR) · European Medicines Agency
Need Naloxone 2 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.